Skip to content

    Stallion India

    STALLION
    Chemicals·16 Oct 2025
    Management Summary

    Stallion India Fluorochemicals Ltd. reported robust Q2 and H1 FY26 results, with significant YoY growth in revenue, EBITDA, and PAT, driven by strong demand and improved product mix. The company is on track to meet its full-year revenue guidance, with over 50% achieved in H1. Strategic backward integration projects in Bhilwara, Mambattu, and Khalapur are progressing, though some have faced delays due to external factors and redesigns, with funding primarily from internal accruals. Management remains confident in achieving future growth targets and margin expansion through these initiatives.

    Highlights

    6
    • Q2 FY26 total revenues stood at INR 105.75 crores, making a solid 55.6% YoY growth driven by higher volumes, improved product mix and strong demand.

    • EBITDA for Q2 FY26 surged nearly seven-fold to INR 15.77 crores with margins expanding to 14.9%.

    • PAT for Q2 FY26 increased impressively to INR 11.42 crores.

    • H1 FY26 total revenue reached INR 216.3 crores, representing a 52.8% YoY growth.

    • H1 FY26 PAT increased by 135% to INR 21.78 crores, underscoring operational leverage.

    • Already achieved over 50% of full-year revenue guidance of INR 430 crores within the first half year.

    Concerns

    3
    • Challenging macroeconomic backdrop characterized by global tariff-related headwinds and cyclical slowdown in certain sectors.

    • Capacity expansion delays at Mambattu facility due to severe flooding and subsequent redesign, pushing operational timeline to January end.

    • Khalapur plant redesign due to upgrade from 200 bar to 300 bar systems, pushing operational timeline to December end or January max.

    What Changed2

    vs Q3 FY26

    Guidance items14 → 15 (+1)Risks discussed2 → 7 (+5)
    Key financials

    Metrics

    7

    Periods

    2

    Headline

    3
    • H1 FY26 Revenue
      ₹216.3 Cr
      YoY+52.8%
    • H1 FY26 EBITDA
      ₹13.14 Cr
      YoY+100%
    • H1 FY26 PAT
      ₹21.78 Cr
      YoY+135%

    Q2 FY26

    4
    • Revenue
      ₹105.75 Cr
      YoY+55.6%
    • EBITDA
      ₹15.77 Cr
      YoY+6%
    • EBITDA Margin
      14.9%
    • PAT
      ₹11.42 Cr

    Capital allocation

    1
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    entirely through internal accruals for Mambattu, Khalapur, and Bhilwara R32 plant

    Guidance & targets

    15
    CategoryTargetPriority
    Revenue
    Full-year revenue guidance
    INR 430 crores
    High
    Revenue
    Bhilwara R32 plant peak revenue potential
    INR 500-700 crores
    High
    Revenue
    Mambattu & Helium first year revenue
    INR 50 crores each
    High
    Revenue
    Bhilwara first year revenue (6 months)
    INR 250 crores
    High
    Revenue
    Bhilwara next year revenue
    INR 500 crores
    High
    Revenue
    Overall next year revenue
    INR 850 crores
    Medium
    Revenue Growth
    CAGR growth
    30-35%
    High
    Profitability
    Operating margins enhancement
    3-4%
    High
    Profitability
    Bhilwara R32 plant PAT margin
    22-24%
    High
    Profitability
    Helium PAT level
    16-18%
    High
    Profitability
    Overall next year margins
    22-24%
    High
    Capacity Utilization
    Bhilwara first year utilization
    50%
    High
    Project Timeline
    Khalapur plant operational
    December end or January max
    High
    Project Timeline
    Mambattu plant operational
    January end
    High
    Project Timeline
    Bhilwara R32 plant operational
    July 2026
    High

    Khalapur Plant Commissioning

    December end or January max
    CurrentConstruction almost over, fit-out starting
    TargetOperational

    Why it matters

    This plant is a key part of capacity expansion and will contribute to revenue and margin growth.

    Basically, we would expect that by December end, we should be operational in the Khalapur facility.

    How to verify

    guidance_and_targets[metric='Khalapur plant operational']

    Risks & concerns

    7
    RiskSeverity

    Macroeconomic Headwinds and Cyclicality

    Challenging macroeconomic backdrop with global tariff-related headwinds and cyclical slowdown in certain sectors. Product cyclicality (e.g., helium prices) is managed by diversification.Management acknowledged

    medium

    Raw Material Sourcing Dependency on China

    80-85% of the fluorochemical industry's raw materials originate from China, posing potential geopolitical supply risks. Company is actively looking for non-China sources for future manufacturing.Analyst acknowledged

    medium

    Uncertainty in HFC Quota System

    The modalities for the HFC quota system post-2028 are not yet finalized by the government, creating some uncertainty for future operations, though quotas are expected to be tradable.Management acknowledged

    medium

    Capacity Expansion Delays

    Mambattu facility faced severe flooding and subsequent redesign, delaying operational readiness to January end. Khalapur plant also required redesign for 300 bar systems, pushing its timeline to December end/January max.Management acknowledged

    medium

    Long Gestation for Semiconductor Product Approvals

    Selling to semiconductor manufacturers requires a 2-3 year approval, verification, and reliability process, including global partner approvals, which is a long gestation period.Management acknowledged

    medium

    R32 Overcapacity in India

    Current Indian R32 manufacturing capacity (30-40k tonnes) significantly exceeds domestic demand (16-18k tonnes), necessitating exports for profitable operations.Management acknowledged

    medium

    China's Influence on Global Pricing

    China, controlling 85-90% of global capacity, acts as a price setter, which can lead to price volatility based on their production decisions.Management acknowledged

    medium

    Q&A highlights

    8

    “We import from a mix of places. We import from Japan. We import from China. We import from Middle-East also now, and we import from the U.S. and Europe, it is a mix. We've been moving away. But to answer your question, the majority part, 80%, 85% of the fluorochemical industry operates from China. So directly, indirectly, you would be working with China.”

    Clarifies the current raw material sourcing strategy, including significant reliance on China, and the company's efforts to diversify.

    asked by Shreya Masalia

    3 min read6 chapters

    Detailed Narrative

    01

    Q2 & H1 FY26 Performance Overview

    Stallion India Fluorochemicals Ltd. reported strong financial results for Q2 and H1 FY26. Q2 FY26 total revenues reached INR 105.75 crores, marking a 55.6% YoY growth. EBITDA for the quarter surged nearly seven-fold to INR 15.77 crores, with margins expanding to 14.9%, and PAT increased impressively to INR 11.42 crores. For the first half of FY26, total revenue was INR 216.3 crores (52.8% YoY growth), EBITDA almost doubled to INR 13.14 crores, and PAT increased by 135% to INR 21.78 crores. The company has already achieved over 50% of its full-year revenue guidance of INR 430 crores.

    02

    Strategic Growth Initiatives & Backward Integration

    The company is pursuing a strategic integration roadmap, including a 10,000 metric ton R32 manufacturing facility in Bhilwara, Rajasthan, to provide backward integration and control over critical raw materials. This initiative aims to enhance cost competitiveness and supply reliability. Additionally, the upcoming Mambattu facility in Andhra Pradesh will boost blending and debulking capacity for HFO refrigerants and specialty gases, while also adding semiconductor and helium-processing capabilities. These efforts are expected to enhance operating margins by 3-4% and contribute to a targeted 30-35% CAGR growth over the next three years.

    03

    Capacity Expansion & Project Timelines

    Several capacity expansion projects are underway. The Khalapur plant is expected to be operational by December end or January max, following a complete redesign to upgrade to 300 bar systems. The Mambattu facility, after facing severe flooding and a 2.5x enhancement, is now projected to be operational by January end. The Bhilwara R32 plant, requiring a minimum CapEx of INR 200 crores, is being funded through internal accruals and is targeted for operational readiness by July 2026. Management noted that the initial phase of Bhilwara focuses solely on R32 manufacturing to compress the timeline from 18 to 9 months.

    04

    HFC Quota System and Market Dynamics

    The upcoming HFC quota system, expected by 2028, will be based on baseline years 2024-2026. Management confirmed that these quotas will be tradable, both within and outside India, creating a potential monetization opportunity. They also highlighted that current Indian R32 manufacturing capacity (30-40k tonnes) significantly exceeds domestic demand (16-18k tonnes), making exports a crucial component for profitability. The government's policy aims to shift the industry towards lower Global Warming Potential (GWP) products, which the company is aligning with through HFO blends.

    05

    Helium Business & Semiconductor Gases

    The company is expanding its footprint in liquid helium and high-purity semiconductor gases, targeting India's emerging electronic, solar, and fiber optic industries. Helium, a natural product, requires specialized refining and handling in liquid form at -257°C, with stringent purity requirements (e.g., 6N for semiconductors). Stallion is upgrading its Khalapur plant to handle 300 bar systems, aligning with the highest industry standards. The semiconductor segment, despite a long 2-3 year approval process, is viewed as highly profitable with significant growth potential due to India's self-reliance push.

    06

    Growth Outlook & Margin Expansion

    Stallion is confident in achieving its FY26 growth targets, with H2 traditionally being a stronger period. The Bhilwara R32 plant is projected to achieve peak revenues of INR 500-700 crores with a PAT margin of 22-24%. The helium business is expected to generate a PAT level of 16-18%. Overall, with the new capacities and backward integration, the company anticipates next year's revenue to be around INR 850 crores with margins increasing to 22-24%. Management emphasized a focus on sustainable, long-term growth and maximizing return on investment.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.